Modeling acute promyelocytic leukemia in the mouse: New insights in the pathogenesis of human leukemias

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 1, 2001, Pages 231-248

  Merghoub, Taha ^a   Gurrieri, Carmela ^a   Piazza, Francesco ^a   Pandolfi, Pier Paolo ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

Cancer; Chromosomal translocation; Cytogenetics; Leukemia

Indexed keywords

CHIMERIC PROTEIN; GENE PRODUCT; NUCLEOPHOSMIN; PROTEIN NUMA; PROTEIN PLZF; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; STAT5B PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 17; CHROMOSOME TRANSLOCATION; FUSION GENE; LEUKEMOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; X CHROMOSOME INACTIVATION;

MUS MUSCULUS;

EID: 0035045676     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0385     Document Type: Article

References (92)

1. Pathogenesis and management of acute promyelocytic leukemia
2. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications
3. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
4. Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia
5. Acute promyelocytic leukemia: From genetics to treatment
6. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia
7. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia
8. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
9. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
10. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties
11. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
12. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17) (q23;q21) in a patient with acute promyelocytic leukemia
13. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosminretinoic acid receptor fusion
14. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
15. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
16. Acute promyelocytic leukemia
17. A decade of molecular biology of retinoic acid receptors
18. Histone acetylation in chromatin structure and transcription
19. Retinoids in cancer therapy
20. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma
21. The puzzling multiple lives of PML and its role in the genesis of cancer
22. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML
23. Identification of a novel nuclear domain
24. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells
25. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion
26. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
27. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
28. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
29. The transcriptional role of PML and the nuclear body
30. The POZ domain: A conserved protein-protein interaction motif
31. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein
32. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis
33. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A
34. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
35. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma')
36. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody
37. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals
38. Major nucleolar proteins shuttle between nucleus and cytoplasm
39. Everything you have ever wanted to know about Yin Yang 1
40. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication
41. NuMA is required for the organization of microtubules into aster-like mitotic arrays
42. A new variant translocation in acute promyelocytic leukaemia: Molecular characterization and clinical correlation
43. Binding of matrix attachment regions to lamin polymers involves single-stranded regions and the minor groove
44. Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA
45. STATs and gene regulation
46. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs)
47. Signal transduction by the GM-CSF, IL-3 and IL-5 receptors
48. The JAK/STAT pathway
49. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor
50. Stat5a and Stat5b: Fraternal twins of signal transduction and transcriptional activation
51. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
52. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences
53. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice
54. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice
55. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RAR alpha and NPM-RAR alpha
56. A PMLRAR alpha transgene initiates murine acute promyelocytic leukemia
57. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages
58. Distinct interactions of PML-RAR alpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL
59. Two critical hits for promyelocytic leukemia
60. Leukemia initiated by PML-RAR alpha: The PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
61. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RAR alpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
62. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia
63. Mutant AF-2 domain of PML-RAR alpha in retinoic acid-resistant NB4 cells: Differentiation induced by RA is triggered directly through PML-RAR alpha and its down-regulation in acute promyelocytic leukemia
64. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation
65. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia
66. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia
67. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
68. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: Cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial
69. RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: A molecular and laboratory - Clinical correlative study
70. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
71. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes
72. The RAR alpha-PLZF chimera associated with acute promyelocytic leukemia has retained a sequence-specific DNA-binding domain
73. PLZF controls cell proliferation and apoptosis through transrepression of hox genes
74. Promyelocytic leukemia translocation gene, PLZF, encodes a transcriptional repressor targeting HoxB2 expression
75. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors
76. A bcr-3 isoform of RARalpha-PML potentiates the development of PML - RAR alpha-driven acute promyelocytic leukemia
77. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11
78. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene
79. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors
80. The use of "knock-in" targeted transgenesis to direct exogenous gene expression to discrete stages of hematopoietic development
81. Role of PML in cell growth and the retinoic acid pathway
82. PML is essential for multiple apoptotic pathways
83. A role for PML and the nuclear body in genomic stability
84. Plzf regulates limb and axial skeletal patterning
85. The role of homeobox genes in normal hematopoiesis and hematological malignancies
86. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells
87. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
88. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: A common mechanism for transformation by tyrosine kinase fusion proteins
89. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
90. Star5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
91. Role of PML in tumor suppression